✦ LIBER ✦

Sweet's syndrome in chronic lymphocytic leukemia associated with neutropenic fever and granulocyte colony stimulation factor

✍ Scribed by Michael A. Thompson; Senait W. Dyson; Stefan Faderl

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 181 KB
Volume: 81
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.20666

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sweet's syndrome associated with sargram

Sweet's syndrome associated with sargramostim (granulocyte-macrophage colony stimulating factor) treatment

✍ Geetika Kumar; Jack M. Bernstein; Jill S. Waibel; Michael A. Baumann 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

## Abstract Sweet's syndrome is an acute febrile neutrophilic dermatosis that is a known complication of the administration of filgrastim, a drug that causes increased neutrophil proliferation and differentiation. This complication has not previously been reported during treatment with sargramostim

Autoantibodies against granulocyte colon

Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus

✍ Bernhard Hellmich; Elena Csernok; Helmut Schatz; Wolfgang L. Gross; Armin Schnab 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

Use of 2-chlorodeoxyadenosine, granulocy

Use of 2-chlorodeoxyadenosine, granulocyte—colony-stimulating factor, and erythropoietin in a jehovah's witness with hairy cell leukemia

✍ Stephen Couban; W. E. C. Wilson 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 2 views

Granulocyte-macrophage colony-stimulatin

Granulocyte-macrophage colony-stimulating factor in association with high-dose chemotherapy (VETOPEC) for childhood solid tumors: A report from the Australia and New Zealand Children's Cancer Study Group

✍ McCowage, Geoffrey B.; White, Les; Carpenter, Paul; Lockwood, Lianne; Toogood, I 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Purpose: Combination chemotherapy with vincristine, etoposide, and high-dose, escalating cyclophosphamide (vetopec) is an effective regimen in pediatric patients with high-risk solid tumors. the toxicity of the regimen is predominantly haematologic. this study addressed the role of recombinant h